To examine whether decreased levels of NFKBIA expression renders TNBC cells resistant to XPO1 inhibition, we treated BT-549 and HCC-1806 NFKBIA knockdown cell lines with selinexor and measured the cellular viability. The gene discussed is XPO1; the disease is hepatocellular carcinoma.